ADA triggered cell cycle arrest in the G1 phase of colorectal cancer cells and inhibited the proliferation of melanoma cells through the arrest of the cell cycle in the S phase, and then inhibited apoptosis by inducing DNA damage (Ocker et al., 2003; Li et al., 2019). This evidence concerns the gene ADA and colorectal cancer.